donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > NVO Novo-Nordisk A/S > Detailed Quotes

NVO Novo-Nordisk A/S

108.300
-4.590-4.07%
Close 06/28 16:00 ET
108.30000.00%
Pre Mkt Price 06/29 04:15 ET
High
109.970
Open
109.250
Turnover
162.01M
Low
108.230
Pre Close
112.890
Volume
1.48M
Market Cap
246.55B
P/E(TTM)
34.15
52wk High
122.160
Shares
2.28B
P/E(Static)
34.15
52wk Low
83.291
Float Cap
118.29B
Bid/Ask %
0.00%
Historical High
122.160
Shs Float
1.09B
Volume Ratio
1.02
Historical Low
3.610
Dividend TTM
1.53
Div Yield TTM
2000
P/B
25.69
Dividend LFY
1.41%
Div Yield LFY
1846.72%
Turnover Ratio
0.14%
Amplitude
1.54%
Avg Price
109.112
Lot Size
1
Float Cap
118.29B
Bid/Ask %
0.00%
Historical High
122.160
Shs Float
1.09B
Volume Ratio
1.02
Historical Low
3.610
Dividend TTM
1.53
P/B
25.69
Dividend LFY
1.41%
Turnover Ratio
0.14%
Amplitude
1.54%
Avg Price
109.112
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
CEO: Jorgensen, Lars Fruergaard
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...